Clinical Trial Update: A Long-Term Follow-Up Study of Participants Exposed to REACT

View source ↗

Summary

A long-term follow-up study of participants exposed to REACT is underway, with the trial currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Kidney Disease

Drugs mentioned

• REACT (Renal Autologous Cell Therapy)

Snippet

Sponsor: Prokidney | Conditions: Diabetic Kidney Disease, Chronic Kidney Diseases | Status: RECRUITING